VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones

被引:35
作者
Filippone, Claudia [1 ]
Zhi, Ning [1 ]
Wong, Susan [1 ]
Lu, Jun [1 ]
Kajigaya, Sachiko [1 ]
Gallinella, Giorgio [2 ]
Kakkola, Laura [3 ]
Soderlund-Venermo, Maria [3 ]
Young, Neal S. [1 ]
Brown, Kevin E. [4 ]
机构
[1] NHLBI, Hematol Branch, NIH, Bldg 10 CRC,Rm 3E5272,9000 Rockville Pike, Bethesda, MD 20892 USA
[2] Univ Bologna, Dept Clin & Expt Med, I-40126 Bologna, Italy
[3] Univ Helsinki, Dept Virol, Haartman Inst, FIN-00014 Helsinki, Finland
[4] Hlth Protect Agcy, Ctr Infect, London, England
关键词
parvovirus B19; PLA(2)-like motif; infectious clone;
D O I
10.1016/j.virol.2008.01.002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Three full-length genomic clones (pB19-M20, pB19-FL and pB19-HG1) of parvovirus B 19 were produced in different laboratories. pB19-M20 was shown to produce infectious virus. To determine the differences in infectivity, all three plasmids were tested by transfection and infection assays. All three clones were similar in viral DNA replication, RNA transcription, and viral capsid protein production. However, only pB19-M20 and pB19-HG1 produced infectious virus. Comparison of viral sequences showed no significant differences in ITR or NS regions. In the capsid region, there was a nucleotide sequence difference conferring an amino acid substitution (E176K) in the phospholipase A(2)-like motif of the VP1-unique (VP1u) region. The recombinant VP1u with the E176K mutation bad no catalytic activity as compared with the wild-type. When this mutation was introduced into pB19-M20, infectivity was significantly attenuated, confirming the critical role of this motif Investigation of the original serum from which pB19-FL was cloned confirmed that the phospholipase mutation was present in the native B19 virus. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:444 / 452
页数:9
相关论文
共 43 条
  • [11] The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity
    Dorsch, S
    Liebisch, G
    Kaufmann, B
    von Landenberg, P
    Hoffmann, JH
    Drobnik, W
    Modrow, S
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (04) : 2014 - 2018
  • [12] The small 11-kDa protein from B19 parvovirus binds growth factor receptor-binding protein 2 in vitro in a Src homology 3 domain/ligand-dependent manner
    Fan, MMY
    Tamburic, L
    Shippam-Brett, C
    Zagrodney, DB
    Astell, CR
    [J]. VIROLOGY, 2001, 291 (02) : 285 - 291
  • [14] SELF-ASSEMBLED B19 PARVOVIRUS CAPSIDS, PRODUCED IN A BACULOVIRUS SYSTEM, ARE ANTIGENICALLY AND IMMUNOGENICALLY SIMILAR TO NATIVE VIRIONS
    KAJIGAYA, S
    FUJII, H
    FIELD, A
    ANDERSON, S
    ROSENFELD, S
    ANDERSON, LJ
    SHIMADA, T
    YOUNG, NS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (11) : 4646 - 4650
  • [15] RISK OF ADVERSE OUTCOMES OF PREGNANCY AFTER HUMAN PARVOVIRUS B19 INFECTION
    KINNEY, JS
    ANDERSON, LJ
    FARRAR, J
    STRIKAS, RA
    KUMAR, ML
    KLIEGMAN, RM
    SEVER, JL
    HURWITZ, ES
    SIKES, RK
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (04) : 663 - 667
  • [16] PURE RED-CELL APLASIA OF 10 YEARS DURATION DUE TO PERSISTENT PARVOVIRUS-B19 INFECTION AND ITS CURE WITH IMMUNOGLOBULIN THERAPY
    KURTZMAN, G
    FRICKHOFEN, N
    KIMBALL, J
    JENKINS, DW
    NIENHUIS, AW
    YOUNG, NS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (08) : 519 - 523
  • [17] KURTZMAN GJ, 1988, LANCET, V2, P1159
  • [18] Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein
    Lu, J
    Zhi, N
    Wong, S
    Brown, KE
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (04) : 582 - 590
  • [19] A NOVEL PROTEIN ENCODED BY SMALL RNAS OF PARVOVIRUS B19
    LUO, WX
    ASTELL, CR
    [J]. VIROLOGY, 1993, 195 (02) : 448 - 455
  • [20] Parvovirus-associated arthritis
    Matsumura, M
    [J]. AMERICAN JOURNAL OF MEDICINE, 2001, 111 (03) : 241 - 241